Contrasting OptimizeRx (NASDAQ:OPRX) & Triple P (OTCMKTS:TPPPF)

Triple P (OTCMKTS:TPPPFGet Free Report) and OptimizeRx (NASDAQ:OPRXGet Free Report) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations and institutional ownership.

Earnings & Valuation

This table compares Triple P and OptimizeRx”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Triple P N/A N/A N/A N/A N/A
OptimizeRx $109.43 million 0.89 $5.13 million $0.35 14.87

OptimizeRx has higher revenue and earnings than Triple P.

Volatility & Risk

Triple P has a beta of 0.25, meaning that its stock price is 75% less volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Triple P and OptimizeRx, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Triple P 0 0 0 0 0.00
OptimizeRx 1 2 6 0 2.56

OptimizeRx has a consensus price target of $13.43, suggesting a potential upside of 157.99%. Given OptimizeRx’s stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than Triple P.

Institutional and Insider Ownership

76.5% of OptimizeRx shares are owned by institutional investors. 39.0% of Triple P shares are owned by insiders. Comparatively, 5.6% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Triple P and OptimizeRx’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Triple P N/A N/A N/A
OptimizeRx 6.37% 10.86% 7.93%

Summary

OptimizeRx beats Triple P on 9 of the 10 factors compared between the two stocks.

About Triple P

(Get Free Report)

Triple P. N.V. provides information and communication technology (ICT) infrastructure solutions. Its services include ICT security, cloud, managed services, managed IP telephony, professional services, business continuity, unified communications, and cloud migration. The company serves care, education, government, and commercial services sectors. Triple P. N.V. was founded in 1989 and is headquartered in Nieuwegein, the Netherlands.

About OptimizeRx

(Get Free Report)

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Receive News & Ratings for Triple P Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Triple P and related companies with MarketBeat.com's FREE daily email newsletter.